Phase I/II first-in-human study of APB-101

Trial Profile

Phase I/II first-in-human study of APB-101

Phase of Trial: Phase I/II

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs APB-101 (Primary)
  • Indications Alpha 1-antitrypsin deficiency
  • Focus Adverse reactions; First in man; Therapeutic Use
  • Most Recent Events

    • 28 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top